Emond J - Search Results

1

Characterization of human bronchial epithelial cells immortalized by the E6 and E7 genes of human papillomavirus type 16.

Viallet J, Liu C, Emond J, Tsao MS. Viallet J, et al. Among authors: emond j. Exp Cell Res. 1994 May;212(1):36-41. doi: 10.1006/excr.1994.1115. Exp Cell Res. 1994. PMID: 8174640

2

Annulate lamellae in a large cell lung carcinoma cell line with high expression of tyrosine kinase receptor and proto-oncogenes.

Wang NS, Liu C, Emond J, Tsao MS. Wang NS, et al. Among authors: emond j. Ultrastruct Pathol. 1992 Jul-Aug;16(4):439-49. doi: 10.3109/01913129209057829. Ultrastruct Pathol. 1992. PMID: 1354400

3

Genetic alteration of chromosome 8 is a common feature of human mammary epithelial cell lines transformed in vitro with benzo[a]pyrene.

Caruso JA, Reiners JJ Jr, Emond J, Shultz T, Tainsky MA, Alaoui-Jamali M, Batist G. Caruso JA, et al. Among authors: emond j. Mutat Res. 2001 Jan 25;473(1):85-99. doi: 10.1016/s0027-5107(00)00140-8. Mutat Res. 2001. PMID: 11166028

4

Scrotal orchiectomy for a large testicular seminoma.

Lo KC, Wong C, Emond J, Aprikian AG. Lo KC, et al. Among authors: emond j. Can J Urol. 2001 Apr;8(2):1234-6. Can J Urol. 2001. PMID: 11375787

5

Important prognostic value of standardized objective criteria of response in stage D2 prostatic carcinoma.

Labrie F, Dupont A, Giguere M, Cusan L, Bergeron N, Emond J, Monfette G, Lacourciere Y, Boucher H, Lachance R. Labrie F, et al. Among authors: emond j. Eur J Cancer Clin Oncol. 1988 Dec;24(12):1869-78. doi: 10.1016/0277-5379(88)90100-9. Eur J Cancer Clin Oncol. 1988. PMID: 3220084

6

Combination therapy with castration and flutamide: today's treatment of choice for prostate cancer.

Labrie F, Dupont A, Cusan L, Manhès G, Bergeron N, Lacourcière Y, Pineault S, Bélanger A, Monfette G, Emond J. Labrie F, et al. Among authors: emond j. J Steroid Biochem. 1989 Oct;33(4B):817-21. doi: 10.1016/0022-4731(89)90499-8. J Steroid Biochem. 1989. PMID: 2689788 Review.

7

Combination therapy with flutamide and castration (LHRH agonist or orchiectomy) in previously untreated patients with clinical stage D2 prostate cancer: today's therapy of choice.

Labrie F, Dupont A, Cusan L, Giguere M, Bergeron N, Borsanyi JP, Lacourciere Y, Belanger A, Emond J, Monfette G, et al. Labrie F, et al. Among authors: emond j. J Steroid Biochem. 1988;30(1-6):107-17. doi: 10.1016/0022-4731(88)90083-0. J Steroid Biochem. 1988. PMID: 3290578 Clinical Trial.

8

Benefits of combination therapy with flutamide in patients relapsing after castration.

Labrie F, Dupont A, Giguere M, Borsanyi JP, Lacourciere Y, Monfette G, Emond J, Bergeron N. Labrie F, et al. Among authors: emond j. Br J Urol. 1988 Apr;61(4):341-6. doi: 10.1111/j.1464-410x.1988.tb13971.x. Br J Urol. 1988. PMID: 3289676

9

Anti-hormone treatment for prostate cancer relapsing after treatment with flutamide and castration. Addition of aminoglutethimide and low dose hydrocortisone to combination therapy.

Labrie F, Dupont A, Bélanger A, Cusan L, Brochu M, Turina E, Pinault S, Lacourciere Y, Emond J. Labrie F, et al. Among authors: emond j. Br J Urol. 1989 Jun;63(6):634-8. doi: 10.1111/j.1464-410x.1989.tb05260.x. Br J Urol. 1989. PMID: 2752257

10

Combination therapy with flutamide and castration (orchiectomy or LHRH agonist): the minimal endocrine therapy in both untreated and previously treated patients.

Labrie F, Dupont A, Giguere M, Borsanyi JP, Lacourciere Y, Belanger A, Lachance R, Emond J, Monfette G. Labrie F, et al. Among authors: emond j. J Steroid Biochem. 1987;27(1-3):525-32. doi: 10.1016/0022-4731(87)90350-5. J Steroid Biochem. 1987. PMID: 2961937

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

500 results

Search Page